Ann Dermatol.  2006 Jun;18(1):14-17. 10.5021/ad.2006.18.1.14.

Treatment of Keratoacanthoma with 5% Imiquimod Cream

Affiliations
  • 1Department of Dermatology, Korea University Ansan Hospital, Kyunggido, Korea. kumcihk @unitel.co.kr

Abstract

Keratoacanthoma is a rapidly growing tumor that histologically resembles squamous cell carcinoma. Surgical excision is a desirable therapeutic option, but several other treatment modalities are available. We report on two cases of keratoacanthoma that were treated with imiquimod 5% cream. Imiquimod was applied daily for the first 6 or 7 days, and then reduced to alternate days according to the tolerance and erythema severity of the patient. In both patients, the tumors fully regressed after five weeks of treatment.

Keyword

Imiquimod 5% cream; Keratoacanthoma

MeSH Terms

Carcinoma, Squamous Cell
Erythema
Humans
Keratoacanthoma*

Cited by  2 articles

Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
Hye Chan Jeon, Mira Choi, Seung Hwan Paik, Chang Ho Ahn, Hyun Sun Park, Kwang Hyun Cho
Ann Dermatol. 2011;23(3):357-361.    doi: 10.5021/ad.2011.23.3.357.

A Case of Cutaneous Horn Originating from Keratoacanthoma
Jung Hoon Yang, Dae Hyun Kim, Jong Suk Lee, Moon Kyun Cho, Sang Hoon Lee, Sung Yul Lee, Hyun Deuk Cho
Ann Dermatol. 2011;23(1):89-91.    doi: 10.5021/ad.2011.23.1.89.

Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr